Paul A. Friedman's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 24,520 Common Stock done at an average price of $15.8 . Disclosure was reported to the exchange on Jan. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 09 Jan 2026 | 24,520 | 211,684 (1%) | 0% | 15.8 | 387,416 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 24,520 | 280 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 517.86 per share. | 09 Jan 2026 | 2,450 | 202,553 (1%) | 0% | 517.9 | 1,268,755 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 525.05 per share. | 09 Jan 2026 | 2,432 | 194,222 (1%) | 0% | 525.0 | 1,276,916 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 515.81 per share. | 09 Jan 2026 | 1,996 | 205,769 (1%) | 0% | 515.8 | 1,029,561 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 526.97 per share. | 09 Jan 2026 | 1,560 | 191,596 (1%) | 0% | 527.0 | 822,071 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 511.98 per share. | 09 Jan 2026 | 1,480 | 210,204 (1%) | 0% | 512.0 | 757,727 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 518.68 per share. | 09 Jan 2026 | 1,363 | 201,190 (1%) | 0% | 518.7 | 706,966 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 514.68 per share. | 09 Jan 2026 | 1,345 | 207,765 (1%) | 0% | 514.7 | 692,246 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 524.10 per share. | 09 Jan 2026 | 1,199 | 196,654 (1%) | 0% | 524.1 | 628,394 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 513.11 per share. | 09 Jan 2026 | 1,094 | 209,110 (1%) | 0% | 513.1 | 561,340 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 526.00 per share. | 09 Jan 2026 | 1,066 | 193,156 (1%) | 0% | 526.0 | 560,717 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 523.00 per share. | 09 Jan 2026 | 970 | 197,853 (1%) | 0% | 523.0 | 507,307 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 519.88 per share. | 09 Jan 2026 | 846 | 200,344 (1%) | 0% | 519.9 | 439,822 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 521.98 per share. | 09 Jan 2026 | 840 | 198,823 (1%) | 0% | 522.0 | 438,461 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 516.84 per share. | 09 Jan 2026 | 766 | 205,003 (1%) | 0% | 516.8 | 395,896 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 529.16 per share. | 09 Jan 2026 | 691 | 190,330 (1%) | 0% | 529.2 | 365,653 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 521.03 per share. | 09 Jan 2026 | 681 | 199,663 (1%) | 0% | 521.0 | 354,823 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 540.36 per share. | 09 Jan 2026 | 600 | 187,204 (1%) | 0% | 540.4 | 324,215 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 528.18 per share. | 09 Jan 2026 | 575 | 191,021 (1%) | 0% | 528.2 | 303,702 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 536.88 per share. | 09 Jan 2026 | 487 | 188,364 (1%) | 0% | 536.9 | 261,459 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 539.23 per share. | 09 Jan 2026 | 480 | 187,804 (1%) | 0% | 539.2 | 258,831 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 536.02 per share. | 09 Jan 2026 | 473 | 188,851 (1%) | 0% | 536.0 | 253,538 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 534.16 per share. | 09 Jan 2026 | 332 | 189,472 (1%) | 0% | 534.2 | 177,342 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 09 Jan 2026 | 280 | 187,444 (1%) | 0% | 15.8 | 4,424 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 551.24 per share. | 09 Jan 2026 | 280 | 187,164 (1%) | 0% | 551.2 | 154,348 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 280 | 0 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 530.69 per share. | 09 Jan 2026 | 280 | 189,884 (1%) | 0% | 530.7 | 148,592 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 529.77 per share. | 09 Jan 2026 | 166 | 190,164 (1%) | 0% | 529.8 | 87,941 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 535.29 per share. | 09 Jan 2026 | 148 | 189,324 (1%) | 0% | 535.3 | 79,223 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 532.50 per share. | 09 Jan 2026 | 80 | 189,804 (1%) | 0% | 532.5 | 42,600 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 537.85 per share. | 09 Jan 2026 | 80 | 188,284 (1%) | 0% | 537.9 | 43,028 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 545.80 per share. | 09 Jan 2026 | 40 | 187,164 (1%) | 0% | 545.8 | 21,832 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 24,800 | 24,800 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 10 Dec 2025 | 24,800 | 211,964 (1%) | 0% | 15.8 | 391,840 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 551.67 per share. | 10 Dec 2025 | 7,193 | 198,887 (1%) | 0% | 551.7 | 3,968,129 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 552.74 per share. | 10 Dec 2025 | 5,533 | 193,354 (1%) | 0% | 552.7 | 3,058,332 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 553.83 per share. | 10 Dec 2025 | 5,001 | 188,353 (1%) | 0% | 553.8 | 2,769,728 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 550.93 per share. | 10 Dec 2025 | 4,316 | 206,080 (1%) | 0% | 550.9 | 2,377,826 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 555.00 per share. | 10 Dec 2025 | 1,029 | 187,324 (1%) | 0% | 555.0 | 571,091 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 547.75 per share. | 10 Dec 2025 | 624 | 211,340 (1%) | 0% | 547.7 | 341,794 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 548.51 per share. | 10 Dec 2025 | 535 | 210,805 (1%) | 0% | 548.5 | 293,451 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 549.99 per share. | 10 Dec 2025 | 409 | 210,396 (1%) | 0% | 550.0 | 224,945 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 555.39 per share. | 10 Dec 2025 | 160 | 187,164 (1%) | 0% | 555.4 | 88,862 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 13 Aug 2025 | 129,172 | 316,336 (2%) | 0% | 9.4 | 1,220,675 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 129,172 | 0 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 372.39 per share. | 13 Aug 2025 | 28,976 | 215,485 (1%) | 0% | 372.4 | 10,790,486 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 373.35 per share. | 13 Aug 2025 | 24,166 | 191,319 (1%) | 0% | 373.3 | 9,022,330 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 371.53 per share. | 13 Aug 2025 | 22,710 | 244,461 (1%) | 0% | 371.5 | 8,437,340 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 369.44 per share. | 13 Aug 2025 | 7,992 | 275,048 (1%) | 0% | 369.4 | 2,952,555 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 370.44 per share. | 13 Aug 2025 | 7,877 | 267,171 (1%) | 0% | 370.4 | 2,917,943 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 367.31 per share. | 13 Aug 2025 | 7,119 | 289,828 (1%) | 0% | 367.3 | 2,614,888 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 368.34 per share. | 13 Aug 2025 | 6,788 | 283,040 (1%) | 0% | 368.3 | 2,500,325 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 374.38 per share. | 13 Aug 2025 | 4,155 | 187,164 (1%) | 0% | 374.4 | 1,555,563 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 364.02 per share. | 13 Aug 2025 | 3,529 | 301,815 (1%) | 0% | 364.0 | 1,284,639 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 360.27 per share. | 13 Aug 2025 | 3,153 | 311,128 (2%) | 0% | 360.3 | 1,135,938 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 366.22 per share. | 13 Aug 2025 | 3,152 | 296,947 (1%) | 0% | 366.2 | 1,154,330 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 363.08 per share. | 13 Aug 2025 | 2,591 | 305,344 (1%) | 0% | 363.1 | 940,731 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 361.13 per share. | 13 Aug 2025 | 1,754 | 309,374 (2%) | 0% | 361.1 | 633,424 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 365.19 per share. | 13 Aug 2025 | 1,716 | 300,099 (1%) | 0% | 365.2 | 626,671 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 358.23 per share. | 13 Aug 2025 | 1,600 | 314,736 (2%) | 0% | 358.2 | 573,171 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 362.29 per share. | 13 Aug 2025 | 1,439 | 307,935 (1%) | 0% | 362.3 | 521,332 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 359.31 per share. | 13 Aug 2025 | 455 | 314,281 (2%) | 0% | 359.3 | 163,485 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 43,605 | 129,172 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 11 Aug 2025 | 43,605 | 230,769 (1%) | 0% | 9.4 | 412,067 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 357.93 per share. | 11 Aug 2025 | 8,434 | 192,796 (1%) | 0% | 357.9 | 3,018,786 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 355.00 per share. | 11 Aug 2025 | 6,546 | 211,568 (1%) | 0% | 355.0 | 2,323,856 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 355.97 per share. | 11 Aug 2025 | 5,244 | 206,324 (1%) | 0% | 356.0 | 1,866,710 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 356.94 per share. | 11 Aug 2025 | 5,094 | 201,230 (1%) | 0% | 356.9 | 1,818,251 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 358.83 per share. | 11 Aug 2025 | 5,032 | 187,764 (1%) | 0% | 358.8 | 1,805,615 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 354.06 per share. | 11 Aug 2025 | 4,768 | 218,114 (1%) | 0% | 354.1 | 1,688,137 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.93 per share. | 11 Aug 2025 | 3,303 | 227,466 (1%) | 0% | 350.9 | 1,159,113 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 3,203 | 172,777 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 11 Aug 2025 | 3,203 | 190,367 (1%) | 0% | 9.4 | 30,268 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 351.59 per share. | 11 Aug 2025 | 3,202 | 224,264 (1%) | 0% | 351.6 | 1,125,806 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.19 per share. | 11 Aug 2025 | 2,903 | 187,464 (1%) | 0% | 350.2 | 1,016,605 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 352.61 per share. | 11 Aug 2025 | 1,382 | 222,882 (1%) | 0% | 352.6 | 487,309 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 359.81 per share. | 11 Aug 2025 | 600 | 187,164 (1%) | 0% | 359.8 | 215,886 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 351.04 per share. | 11 Aug 2025 | 300 | 187,164 (1%) | 0% | 351.0 | 105,312 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.03 per share. | 18 Jul 2025 | 1,400 | 187,164 (1%) | 0% | 350.0 | 490,044 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 18 Jul 2025 | 1,400 | 188,564 (1%) | 0% | 9.5 | 13,230 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2025 | 1,400 | 175,980 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 16 Jul 2025 | 26,176 | 213,340 (1%) | 0% | 9.4 | 247,363 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 26,176 | 180,080 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 354.65 per share. | 16 Jul 2025 | 6,851 | 194,148 (1%) | 0% | 354.6 | 2,429,697 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 355.61 per share. | 16 Jul 2025 | 5,784 | 188,364 (1%) | 0% | 355.6 | 2,056,860 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.17 per share. | 16 Jul 2025 | 5,541 | 207,799 (1%) | 0% | 350.2 | 1,940,275 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 2,700 | 177,380 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 16 Jul 2025 | 2,700 | 189,864 (1%) | 0% | 9.5 | 25,515 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 351.38 per share. | 16 Jul 2025 | 2,371 | 205,428 (1%) | 0% | 351.4 | 833,131 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 353.82 per share. | 16 Jul 2025 | 2,319 | 200,999 (1%) | 0% | 353.8 | 820,507 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 352.67 per share. | 16 Jul 2025 | 2,110 | 203,318 (1%) | 0% | 352.7 | 744,133 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.10 per share. | 16 Jul 2025 | 2,000 | 187,864 (1%) | 0% | 350.1 | 700,203 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 356.62 per share. | 16 Jul 2025 | 1,200 | 187,164 (1%) | 0% | 356.6 | 427,941 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 351.57 per share. | 16 Jul 2025 | 700 | 187,164 (1%) | 0% | 351.6 | 246,098 | Common Stock |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 1,290 | 1,290 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 715 | 187,164 (1%) | 0% | 0 | Common Stock | |
| Prelude Therapeutics Inc | Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 38,000 | 38,000 | - | - | Director Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 1,105 | 1,105 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 714 | 186,449 (1%) | 0% | 0 | Common Stock | |
| Prelude Therapeutics Inc | Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) |